Patents by Inventor Karen Ann Runcie

Karen Ann Runcie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6066657
    Abstract: A compound of formula (i) ##STR1## has therapeutic utility via inhibition of phosphodiesterase and THF release.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: May 23, 2000
    Assignee: Darwin Discovery, Ltd.
    Inventors: Hazel Joan Dyke, John Gary Montana, Christopher Lowe, Karen Ann Runcie, Alan Findlay Haughan, Verity Margaret Sabin, Duncan Hannah, Louise Picken, Andrew Sharpe
  • Patent number: 5891878
    Abstract: 1-Alkyl-substituted-quinolone-3-carboxamides have therapeutic utility via inhibition of Phosphodiesterase IV esterase and/or Tumour Necrosis Factor activity. The compounds of the invention have the general formula (I): ##STR1## The compounds of the invention encompassed by formula (I) include enantiomers, diastereoisomers and mixtures, including racemic mixtures.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: April 6, 1999
    Assignee: Chiroscience Limited
    Inventors: Steven Colin Beasley, John Gary Montana, Hazel John Dyke, Alan Findlay Haughan, Karen Ann Runcie, David Thomas Manallack, George Martin Buckley, Robert James Maxey, Hannah Jayne Kendall, Andrew Douglas Baxter